REG - Microsaic Systems - Result of Annual General Meeting
RNS Number : 2572CMicrosaic Systems plc17 June 202117 June 2021
Microsaic Systems plc
("Microsaic" or the "Company")
Result of Annual General Meeting
Microsaic Systems plc (AIM:MSYS), the developer of point of need mass spectrometry ("MS") instruments, is pleased to announce that all resolutions proposed at its Annual General Meeting held earlier today were duly passed on a poll, the results of which are set out below:
Votes
For*
% of votes cast
Votes against
% votes cast
Votes withheld
Ordinary Resolutions
1
To approve the audited accounts of the Company for the year ended 31 December 2020, together with the Directors' Report and Auditors' Report thereon
3,523,708,945
100.000
-
-
2,407,506
2
To re-appoint Saffery Champness LLP as auditors to the Company, and that the Board be authorised to fix the remuneration of the auditors
3,523,235,738
99.932
2,407,006
0.068
473,707
3
To re-appoint Gerard Brandon as a Director of the Company
3,526,086,451
99.999
30,000
0.001
-
4
To re-appoint Nigel Burton as a Director of the Company
3,526,086,451
99.999
30,000
0.001
-
5
To authorise the Directors to allot equity securities up to an aggregate nominal amount of £202,545
3,523,401,451
99.923
2,715,000
0.077
-
Special Resolutions
6
To disapply statutory pre-emption rights up to an aggregate nominal amount of £151,909
3,429,049,709
97.247
97,066,742
2.753
-
7
To adopt the new Articles of Association of the Company
3,526,086,451
99.999
30,000
0.001
-
* "Votes For" include votes giving the Chairman discretion.
Enquiries:
Microsaic Systems plc
Glenn Tracey, CEO - Bevan Metcalf, FD
+44 (0) 1483 751 577
N+1 Singer (Nominated Adviser & Joint Broker)
+44 (0) 20 7496 3000
Aubrey Powell / George Tzimas (Corporate Finance)
Tom Salvesen (Corporate Broking)
Turner Pope Investments (TPI) Limited (Broker)
Andy Thacker / James Pope
+44 (0) 20 3657 0050
About Microsaic (www.microsaic.com)
Microsaic listed on AIM in 2011 to develop and commercialise micro-engineering chip-based mass spectrometry equipment. Having invested £30m over the last 20 years before and after the IPO, Microsaic has a robust patent portfolio in cutting-edge technology purpose built for "Industry 4.0" which enables analytical detection and characterisation at the point-of-need, whether within a human health environment, conventional laboratory setting, or within a bioprocessing facility for continuous mass spectrometer detection and monitoring of data at any step in the process workflow.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDRAGEANKXFSDFEEA
Recent news on Microsaic Systems
See all newsREG - Microsaic Systems - Company Update
AnnouncementRCS - Microsaic Systems - Company Update
AnnouncementREG - Microsaic Systems - Company Update
AnnouncementREG - Microsaic Systems - Completion of Acquisition
AnnouncementREG - Microsaic Systems - Holding(s) in Company
Announcement